| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Common Stock | Options Exercise | $680K | +16.1K | +528.11% | $42.15 | 19.2K | Aug 15, 2024 | Direct | F1 |
| transaction | INSP | Common Stock | Sale | -$147K | -776 | -4.04% | $189.06 | 18.4K | Aug 15, 2024 | Direct | F2 |
| transaction | INSP | Common Stock | Sale | -$316K | -1.66K | -9.01% | $190.20 | 16.8K | Aug 15, 2024 | Direct | F3 |
| transaction | INSP | Common Stock | Sale | -$398K | -2.07K | -12.36% | $191.92 | 14.7K | Aug 15, 2024 | Direct | F4 |
| transaction | INSP | Common Stock | Sale | -$221K | -1.15K | -7.83% | $192.60 | 13.5K | Aug 15, 2024 | Direct | F5 |
| transaction | INSP | Common Stock | Sale | -$1.58M | -8.13K | -60.07% | $193.92 | 5.41K | Aug 15, 2024 | Direct | F6 |
| transaction | INSP | Common Stock | Sale | -$458K | -2.35K | -43.47% | $194.91 | 3.06K | Aug 15, 2024 | Direct | F7 |
| transaction | INSP | Common Stock | Options Exercise | $205K | +4.86K | +159.06% | $42.15 | 7.92K | Aug 16, 2024 | Direct | |
| transaction | INSP | Common Stock | Sale | -$168K | -900 | -11.37% | $187.10 | 7.02K | Aug 16, 2024 | Direct | F8 |
| transaction | INSP | Common Stock | Sale | -$578K | -3.07K | -43.69% | $188.66 | 3.95K | Aug 16, 2024 | Direct | F9 |
| transaction | INSP | Common Stock | Sale | -$170K | -895 | -22.65% | $189.64 | 3.06K | Aug 16, 2024 | Direct | F10 |
| holding | INSP | Common Stock | 167 | Aug 15, 2024 | By son | ||||||
| holding | INSP | Common Stock | 166 | Aug 15, 2024 | By daughter |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Stock Option (Right to Buy) | Options Exercise | $0 | -16.1K | -76.85% | $0.00 | 4.86K | Aug 15, 2024 | Common Stock | 16.1K | $42.15 | Direct | F11 |
| transaction | INSP | Stock Option (Right to Buy) | Options Exercise | $0 | -4.86K | -100% | $0.00* | 0 | Aug 16, 2024 | Common Stock | 4.86K | $42.15 | Direct | F11 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Includes 27 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated February 27, 2024. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.995 to $189.285. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.08 to $190.845. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.225 to $192.18. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.26 to $193.22. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.4 to $194.32. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.81 to $195.15. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.90 to $187.71. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.255 to $189.24. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote . |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.26 to $189.855. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F11 | The option is fully vested and exercisable. |
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 16, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.